Gene transfer vectors for clinical application
Author(s)
Bibliographic Information
Gene transfer vectors for clinical application
(Methods in enzymology / editors in chief, Sidney P. Colowick, Nathan O. Kaplan, 507)
Academic/Elsevier, c2012
- hbk.
Available at / 32 libraries
-
Academic Information Center, The Jikei University School of Medicine
hbk.QU135||Me850||50712042362
-
No Libraries matched.
- Remove all filters.
Note
Includes indexes
Description and Table of Contents
Description
This volume of Methods in Enzymology looks at Gene Transfer Vectors for Clinical Application. The chapters provide an invaluable resource for academics, researchers and students alike. With an international board of authors, this volume covers such topics as General principles of retrovirus vector design, Chronic granulomatous disease (CGD), Gene therapy for blindness, and Retrovirus genetic strategy and vector design.
Table of Contents
Preface: The successful clinical use of viral vectors for human gene therapy.
General principles of retrovirus vector design
Strategies for retrovirus-based correction of severe, combined immunodeficiency (SCID)
Retrovirus and lentivirus vector design and methods of cell conditioning
Analysis of the clonal repertoire of gene corrected cells in gene therapy
Developing novel lentiviral vectors into clinical products
Lentivirus vectors in beta-thalassemia
Gene Therapy for Chronic Granulomatous Disease
Alternative splicing caused by lentiviral integration in the human genome
Genotoxicity assay for gene therapy vectors in tumor prone Cdkn2a-/- mice
Lentiviral Hematopoietic Cell Gene Therapy for X-linked Adrenoleukodystrophy
Retroviral replicating vectors in cancer
Adeno-associated virus vectorology, manufacturing and clinical applications
Gene Delivery To The Retina: From Mouse To Man
Generation of hairpin-based RNAi vectors for biological and therapeutic application
Recombinant adeno-associated viral vector reference standards
NIH oversight of human gene transfer research involving retroviral, lentiviral and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee draft
Regulatory structures for gene therapy medicinal products in the European Union
by "Nielsen BookData"